← Browse by Condition
Medical Condition
gastrointestinal diseases
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 4, Phase 2
NCT06271538 Phase 4
Recruiting
Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome
Enrollment
60 pts
Location
Malaysia
Sponsor
EP Plus Group Sdn Bhd
NCT06227468
Recruiting
A Clinical Study to Map the HLA Genomic Region in the Greek Population
Enrollment
12,000 pts
Location
Greece
Sponsor
Athens LifeTech Park
NCT05252078 Phase 2
Recruiting
Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients
Enrollment
30 pts
Location
China
Sponsor
Jiangxi Provincial Cancer Hosp...